The Technical Analyst
Select Language :
AVROBIO Inc [AVRO]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

AVROBIO Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

AVROBIO Inc is listed at the  Exchange

0.79% $1.270

America/New_York / 28 mar 2024 @ 12:37


FUNDAMENTALS
MarketCap: 56.97 mill
EPS: 0.270
P/E: 4.70
Earnings Date: May 08, 2024
SharesOutstanding: 44.86 mill
Avg Daily Volume: 0.318 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Sell
Return On Asset: Neutral
DE: Sell
P/E: Sell
Price To Book: Neutral
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 4.70 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
0.80x
Company: PE 4.70 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$2.19
(72.12%) $0.916
Date: 2024-03-28
Expected Trading Range (DAY)

$ 1.206 - 1.334

( +/- 5.04%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-01 Golipour Azadeh Sell 37 334 Restricted Stock Unit
2024-02-01 Golipour Azadeh Buy 37 334 Common Stock
2024-02-05 Golipour Azadeh Sell 12 232 Common Stock
2024-02-01 Ridha Essra Sell 32 834 Restricted Stock Unit
2024-02-01 Ridha Essra Buy 32 834 Common Stock
INSIDER POWER
54.90
Last 100 transactions
Buy: 6 327 240 | Sell: 1 294 974

Forecast: 14:16 - $1.274

Live Trading Signals (every 1 min)

Forecast 1: 12:46 - $1.271
Forecast 2: 13:36 - $1.277
Forecast 3: 14:16 - $1.274
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $1.270 (0.79% )
Volume 0.0208 mill
Avg. Vol. 0.318 mill
% of Avg. Vol 6.53 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for AVROBIO Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for AVROBIO Inc

RSI

Intraday RSI14 chart for AVROBIO Inc

Last 10 Buy & Sell Signals For AVRO

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            AVROBIO Inc

AVRO

AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's product includes AVR-RD-01, a gene therapy for the treatment of Fabry disease. It is also developing AVR-RD-02, which is in phase 1/2 clinical trial for the treatment of type 1 Gaucher disease; AVR-RD-03, for the treatment of Pompe disease; AVR-RD-04 for the treatment of cystinosis; AVR-RD-05 for the treatment of Hunter syndrome; and AVR-RD-06 that is in preclinical stage for the treatment of Gaucher disease type 3. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Last 10 Buy Signals

Date Signal @
PFGMar 28 - 12:38$86.14
LNTHMar 28 - 12:38$61.65
LSXMKMar 28 - 12:37$29.57
FIVEMar 28 - 12:37$181.95
CGMar 28 - 12:37$47.11
MNSTMar 28 - 12:36$59.25
VCLTMar 28 - 12:35$78.39
TLTMar 28 - 12:36$94.82
MIDDMar 28 - 12:35$159.41
ARQTMar 28 - 12:35$9.81

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.